← FDA Drug Approvals (Drugs@FDA)
NUCALA
BLA · Biologics License Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2015-11-04
Drug application
- FDA Application #
BLA125526- Application type
- Biologics License Application
- Brand name
- NUCALA
- Generic name
- MEPOLIZUMAB
- Active ingredients
- MEPOLIZUMAB
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS LYOPHILIZED POWER
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE LLC
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 2015-11-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown